Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Harvard Business School
Cerilliant
Cipla
UBS
Deloitte
Julphar
Chinese Patent Office

Generated: May 20, 2018

DrugPatentWatch Database Preview

CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cephalothin Sodium W/ Sodium Chloride In Plastic Container, and when can generic versions of Cephalothin Sodium W/ Sodium Chloride In Plastic Container launch?

Cephalothin Sodium W/ Sodium Chloride In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Summary for CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER
Drug patent expirations by year for CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER
Synonyms for CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER
(6R,7R)-3-ACETOXYMETHYL-8-OXO-7-(2-THIOPHEN-2-YL-ACETYLAMINO)-5-THIA-1-AZA-BICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE SODIUM
11048-05-8
153-61-7 (Parent)
297760-78-2
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, (6R-trans)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate, monosodium salt
53493-25-7
58-71-9
63-60-5
7-(2-THIENYLACETAMIDO)CEPHALOSPORANIC ACID SODIUM
7-(2-Thienylacetamido)cephalosporanic acid sodium salt
7-(THIOPHENE-2-ACETAMIDO)CEPHALOSPORANIC ACID SODIUM
7-(Thiophene-2-acetamido)cephalosporanic acid sodium salt
7-[2-Thienylacetamido]-cephalosporanic acid
AB02836
AC-15529
AK129742
AKOS015896088
AN-41764
C 4520
C-2720
C08100
C16H15N2NaO6S2
C16H15N2O6S2.Na
C22G6EYP8B
CCG-38923
CEFALOTHIN NA
Cefalothin sodium
Cefalothine
Cefalothine sodium
Cefalotin for impurity B identification, European Pharmacopoeia (EP) Reference Standard
cefalotin sodium
Cefalotin sodium (JP17)
Cefalotin sodium salt
Cefalotin sodium, European Pharmacopoeia (EP) Reference Standard
Cefalotina sodica
Cefalotina sodica [Spanish]
Cephalothin (sodium)
CEPHALOTHIN SODIUM
Cephalothin sodium (USP)
Cephalothin sodium [USAN:USP]
Cephalothin sodium [USAN]
Cephalothin sodium salt
Cephalothin sodium salt, 96.0-101.0%
Cephalothin sodium salt, BioReagent, suitable for cell culture
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER
Cephalothin sodium, Cefalotin sodium
Cephalothin sodium, United States Pharmacopeia (USP) Reference Standard
Cephalotin sodium salt
Cephalotin sodium salt, Antibiotic for Culture Media Use Only
Ceporacin
Cepovenin
Cet Injektionsfl
CHEBI:3542
CHEMBL1632
CS-4850
D00907
D0DT5E
EINECS 200-394-6
EU-0100283
FT-0603065
HE314109
HMS1570O19
HMS1920K11
HMS2091A14
HMS2097O19
HMS3260J08
HMS500E19
HY-B1275
I06-1756
KB-303028
Keflin
Keflin (TN)
Keflin In Plastic Container
Keflin N Injektionsflaschen
KS-1135
Lilly 38253
Lospoven
Lovvalline Injektionsfl
LP00283
LS-150070
MCULE-2927862684
MFCD00072025
Microtin
MLS000069577
MolPort-002-511-511
Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate
Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate (ester)
NCGC00093737-01
NCGC00260968-01
Prestwick_971
s4594
SC-25746
SCHEMBL148785
SMR000058777
sodium (6R, 7R)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate
Sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate
sodium 7beta-(2-thienylacetamido)-3-acetoxymethyl-3-cephem-4-carboxylate
Sodium cefalotin
sodium cefalotin(1-)
Sodium cephalothin
Sodium cephalotin
SPECTRUM1500166
ST24049179
STOCK1N-11912
Synclotin
Tokiosarl Ampullen
Toricelocin
Tox21_500283
UNII-C22G6EYP8B
VUFGUVLLDPOSBC-XRZFDKQNSA-M

US Patents and Regulatory Information for CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER cephalothin sodium INJECTABLE;INJECTION 062422-001 Jan 31, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER cephalothin sodium INJECTABLE;INJECTION 062422-002 Jan 31, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Citi
Johnson and Johnson
Cantor Fitzgerald
McKinsey
Teva
US Department of Justice
Covington
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.